TABLE OF CONTENTS
| | | | Volume 36, Issue 37 (September 2017) | | In this issue Review Original Articles Also new AOP | | | | | Advertisement | | | | | Review | Top | | A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood A R Lourenço and P J Coffer Oncogene 2017 36: 5221-5230; advance online publication, May 15, 2017; 10.1038/onc.2017.151 Abstract | Full Text | | Original Articles | Top | | Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells OPEN D Kawauchi, R J Ogg, L Liu, D J H Shih, D Finkelstein, B L Murphy, J E Rehg, A Korshunov, C Calabrese, F Zindy, T Phoenix, Y Kawaguchi, J Gronych, R J Gilbertson, P Lichter, A Gajjar, M Kool, P A Northcott, S M Pfister and M F Roussel Oncogene 2017 36: 5231-5242; advance online publication, May 15, 2017; 10.1038/onc.2017.110 Abstract | Full Text | | | | Fibulin-3 promotes muscle-invasive bladder cancer A L Han, B A Veeneman, L El-Sawy, K C Day, M L Day, S A Tomlins and E T Keller Oncogene 2017 36: 5243-5251; advance online publication, May 15, 2017; 10.1038/onc.2017.149 Abstract | Full Text | | | | Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma H Goto, R Kariya, E Kudo, Y Okuno, K Ueda, H Katano and S Okada Oncogene 2017 36: 5252-5262; advance online publication, May 8, 2017; 10.1038/onc.2017.138 Abstract | Full Text | | | | Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells H Marzook, S Deivendran, B George, G Reshmi, T R Santhoshkumar, R Kumar and M R Pillai Oncogene 2017 36: 5263-5273; advance online publication, May 15, 2017; 10.1038/onc.2017.19 Abstract | Full Text | | | | Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover H-C Chi, S-L Chen, S-L Lin, C-Y Tsai, W-Y Chuang, Y-H Lin, Y-H Huang, M-M Tsai, C-T Yeh and K-H Lin Oncogene 2017 36: 5274-5284; advance online publication, May 15, 2017; 10.1038/onc.2017.136 Abstract | Full Text | | | | A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer E-J Choi, B-J Jung, S-H Lee, H-S Yoo, E-A Shin, H-J Ko, S Chang, S-Y Kim and S-M Jeon Oncogene 2017 36: 5285-5295; advance online publication, May 15, 2017; 10.1038/onc.2017.153 Abstract | Full Text | | | | Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer M L Read, J C Fong, B Modasia, A Fletcher, W Imruetaicharoenchoke, R J Thompson, H Nieto, J J Reynolds, A Bacon, U Mallick, A Hackshaw, J C Watkinson, K Boelaert, A S Turnell, V E Smith and C J McCabe Oncogene 2017 36: 5296-5308; advance online publication, May 15, 2017; 10.1038/onc.2017.154 Abstract | Full Text | | | | A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma D Kesanakurti, D Maddirela, Y K Banasavadi-Siddegowda, T-H Lai, Z Qamri, N K Jacob, D Sampath, S Mohanam, B Kaur and V K Puduvalli Oncogene 2017 36: 5309-5320; advance online publication, May 22, 2017; 10.1038/onc.2016.261 Abstract | Full Text | | | | CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells Q Wang, J Ma, Y Lu, S Zhang, J Huang, J Chen, J-X Bei, K Yang, G Wu, K Huang, J Chen and S Xu Oncogene 2017 36: 5321-5330; advance online publication, May 22, 2017; 10.1038/onc.2017.161 Abstract | Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | |
No comments:
Post a Comment